세계의 세포 생존률 분석 시장 보고서(2025년)

Cell viability assays are methods employed to assess the ability of cells, tissues, or organs to maintain or recover a state of survival. These assays are utilized to evaluate optimal growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments.

The main products associated with cell viability assays include consumables and instruments. Consumables are items used either once or replaced regularly in the assay process. They find applications in various fields such as basic research, stem cell research, drug discovery and development, clinical and diagnostic applications, and more. These products are utilized by academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell viability assays market research report is one of a series of new reports from The Business Research Company that provides cell viability assays market statistics, including the cell viability assays industry global market size, regional shares, competitors with cell viability assays market share, detailed cell viability assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell viability assays industry. These cell viability assays market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell viability assays market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations).

The cell viability assays market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco-friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells.

The forecast of 9.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. drug development by increasing costs for real-time cell analyzers and 3D assay kits imported from the UK and Sweden, potentially compromising drug safety testing and raising preclinical research costs by 20-30%. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the cell viability assay market is expected to be driven by the increasing adoption of cell-based therapeutics. Cell-based therapeutics involve using living cells for various medical purposes, such as tissue repair, disease treatment, and functional restoration. This trend is supported by advancements in biotechnology, rising investments in regenerative medicine, greater acceptance of cell therapies, and advancements in cell engineering and manufacturing. Cell viability assays play a crucial role in this domain by ensuring the viability, functionality, and safety of therapeutic cells, thereby optimizing treatment outcomes and quality assurance. For example, the American Society of Gene & Cell Therapy reported a rise in trials for non-genetically modified cell therapies in Q1 2023 compared to the previous quarter, indicating the increasing momentum in cell-based therapeutics and its impact on the cell viability assay market.

Leading companies in the cell viability assay market are innovating with advanced cell screening technologies to enhance the efficiency and accuracy of drug discovery processes. These technologies enable high-throughput and precise analysis of cell health and responses, thereby improving experimental conditions and therapeutic development. For instance, Arralyze, a technology company based in Germany, introduced CellShepherd, a state-of-the-art platform for single-cell analysis. Utilizing proprietary nanowell glass arrays, CellShepherd enables real-time monitoring of cell-based assays, offering precise cell dispensing, sterile co-culturing, and imaging capabilities. With AI-driven analysis ensuring accurate cell counting and tracking, CellShepherd meets the growing demand for precise single-cell research across biomedical and life science applications.

In February 2022, BD Biosciences, a US-based medical device company, acquired Cytognos, a biotechnology company headquartered in Spain. This acquisition aims to broaden BD's portfolio in areas such as blood cancer diagnostics, minimal residual disease (MRD) detection, and immune monitoring research. Cytognos specializes in providing cell viability assays and clinical flow cytometry solutions, aligning with BD Biosciences' strategic goals in advancing healthcare technologies.

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell viability assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell viability assays market consists of revenues earned by entities by providing services such as assay development services, assay validation services, cell culture services, and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell viability assays market also includes sales of microscopes, imaging systems, incubators, plate readers, and automated liquid handling systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Viability Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell viability assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell viability assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell viability assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Instruments
• 2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications
• 3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates
• 2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton, Dickinson, and Company; Agilent Technologies Inc.; Lonza Group Ltd.; PerkinElmer Inc.; Sartorius AG; Charles River Laboratories; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Beckman Coulter Inc.; Promega Corporation; Abcam Limited; MP Biomedicals; Cayman Chemical Company; Cell Signaling Technology Inc.; Enzo Biochem Inc.; Creative Bioarray; Abnova Corporation; Biotium; Canvax; Nexcelom Bioscience LLC; G-Biosciences; AAT Bioquest Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Viability Assays market Characteristics

3. Cell Viability Assays market Trends And Strategies

4. Cell Viability Assays market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell Viability Assays Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell Viability Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell Viability Assays market Growth Rate Analysis
• 5.4. Global Cell Viability Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell Viability Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell Viability Assays Total Addressable Market (TAM)

6. Cell Viability Assays market Segmentation

• 6.1. Global Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• 6.2. Global Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Basic Research
• Stem Cell Research
• Drug Discovery And Development
• Clinical And Diagnostic Applications
• Other Applications
• 6.3. Global Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Hospital And Diagnostic Laboratories
• Other End-Users
• 6.4. Global Cell Viability Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Kits
• Assay Plates (96-Well plates)
• Microplates
• 6.5. Global Cell Viability Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spectrophotometers
• Fluorometers
• Microplate Readers
• Flow Cytometers
• Imaging Systems

7. Cell Viability Assays market Regional And Country Analysis

• 7.1. Global Cell Viability Assays market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell Viability Assays market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Viability Assays market

• 8.1. Asia-Pacific Cell Viability Assays market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Viability Assays market

• 9.1. China Cell Viability Assays market Overview
• 9.2. China Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Viability Assays market

• 10.1. India Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Viability Assays market

• 11.1. Japan Cell Viability Assays market Overview
• 11.2. Japan Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Viability Assays market

• 12.1. Australia Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Viability Assays market

• 13.1. Indonesia Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Viability Assays market

• 14.1. South Korea Cell Viability Assays market Overview
• 14.2. South Korea Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Viability Assays market

• 15.1. Western Europe Cell Viability Assays market Overview
• 15.2. Western Europe Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Viability Assays market

• 16.1. UK Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Viability Assays market

• 17.1. Germany Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Viability Assays market

• 18.1. France Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Viability Assays market

• 19.1. Italy Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Viability Assays market

• 20.1. Spain Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Viability Assays market

• 21.1. Eastern Europe Cell Viability Assays market Overview
• 21.2. Eastern Europe Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Viability Assays market

• 22.1. Russia Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Viability Assays market

• 23.1. North America Cell Viability Assays market Overview
• 23.2. North America Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Viability Assays market

• 24.1. USA Cell Viability Assays market Overview
• 24.2. USA Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Viability Assays market

• 25.1. Canada Cell Viability Assays market Overview
• 25.2. Canada Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Viability Assays market

• 26.1. South America Cell Viability Assays market Overview
• 26.2. South America Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Viability Assays market

• 27.1. Brazil Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Viability Assays market

• 28.1. Middle East Cell Viability Assays market Overview
• 28.2. Middle East Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Viability Assays market

• 29.1. Africa Cell Viability Assays market Overview
• 29.2. Africa Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Viability Assays market Competitive Landscape And Company Profiles

• 30.1. Cell Viability Assays market Competitive Landscape
• 30.2. Cell Viability Assays market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickinson, and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell Viability Assays market Other Major And Innovative Companies

• 31.1. Lonza Group Ltd.
• 31.2. PerkinElmer Inc.
• 31.3. Sartorius AG
• 31.4. Charles River Laboratories
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Bio-Techne Corporation
• 31.7. Beckman Coulter Inc.
• 31.8. Promega Corporation
• 31.9. Abcam Limited
• 31.10. MP Biomedicals
• 31.11. Cayman Chemical Company
• 31.12. Cell Signaling Technology Inc.
• 31.13. Enzo Biochem Inc.
• 31.14. Creative Bioarray
• 31.15. Abnova Corporation

32. Global Cell Viability Assays market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Viability Assays market

34. Recent Developments In The Cell Viability Assays market

35. Cell Viability Assays market High Potential Countries, Segments and Strategies

• 35.1 Cell Viability Assays market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell Viability Assays market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell Viability Assays market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer